Precision Oncology: Using Targeted Therapies to Attack Cancer Cells Based on their Specific Mutations.
DOI:
https://doi.org/10.62019/cmtezp75Abstract
Precision oncology represents a paradigm shift in cancer treatment by tailoring therapies to the unique genetic makeup of individual tumors. This approach leverages advanced molecular profiling techniques to identify actionable mutations within cancer cells, enabling the selection of targeted drugs that exploit these vulnerabilities for more effective and less toxic treatment. This article explores the key principles and applications of precision oncology, highlighting its potential to improve patient outcomes and transform cancer care.
Keywords Precision oncology, targeted therapy, personalized medicine, cancer genomics, molecular profiling, biomarker analysis, drug resistance, clinical trials
Downloads
Downloads
Published
Issue
Section
License
All articles published in the Journal of Medical & Health Sciences Review (JMHSR) remain the copyright of their respective authors. JMHSR publishes its content under the Creative Commons Attribution‑NonCommercial 4.0 International License (CC BY‑NC 4.0), which allows readers to freely share, copy, adapt, and build upon the work for non‑commercial purposes, provided proper credit is given to both the authors and the journal.



